Research Degree Student
My research interests include health policy and governance, access to medicines, and the political economy of non-communicable disease (NCD) treatment and prevention. My Doctor of Public Health research is supported by a Doctoral Foreign Study Award from the Canadian Institutes for Health Research (CIHR). I am also a research visitor at the MAP- Centre for Urban Health Solutions at St. Michael’s Hospital in Toronto.
I previously helped establish and served as the Executive Director of the Young Professionals Chronic Disease Network (YP-CDN), a global independent advocacy organization that seeks to mobilize young leaders to promote social justice and health worldwide. I’ve also worked for the Global Alliance for Chronic Diseases and Amref Health Africa in Kenya, and consulted for WHO, Health Action International and the American Cancer Society (Global). I completed a postgraduate research fellowship at the Harvard Global Equity Initiative/Harvard Medical School, earned a Master of Science in Medical Biophysics from the University of Toronto, and a BSc (Hons.) in Biology from Western University, Canada.
LSHTM Doctoral Project Travelling Scholarship, 2018- 2019
The Jackman Foundation Scholar, London Goodenough Association of Canada, 2017-2018
Responsibilities & Affiliations
Expert Advisory Group, Medicines Patent Pool
Board of the Young Professionals Chronic Disease Network
Associate Editor, Globalization & Health Journal
My ongoing DrPH thesis involves a policy study to understand the contextual and political factors influencing implementation of the Essential Medicines List in Kenya to inform improved access to cardiovascular disease medicines.
My Organizational Policy Analysis project involved a qualitative study investigating the acceptability and feasibility of a national essential medicines list in Canada in the context of possible national prescription drug policy change. The study was published in the Canadian Medical Association Journal. The findings were also shared with the Federal Advisory Council on the Implementation of National Pharmacare in 2018, who recommended the need for a national formulary, starting with a list of essential medicines in June 2019.
My doctoral supervisors are Dr. Pablo Perel and Dr. Adrianna Murphy.